Skip to main content
Clinical Trials/CTRI/2020/06/025650
CTRI/2020/06/025650
Completed
Phase 2

A Prospective Cohort Interventional Study Assessing the Safety and Outcome of Unani Medicine as a Prophylaxis in Population at risk of COVID-19

Ministry of AYUSH Government of India0 sites4,500 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Ministry of AYUSH Government of India
Enrollment
4500
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ministry of AYUSH Government of India

Eligibility Criteria

Inclusion Criteria

  • 1\. Population as described in High/Moderate/Low Risk
  • 2\. Individuals who are from the identified containment zone/ quarantine facility with at least 1 confirmed COVID\-19 positive case.
  • 3\. Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study

Exclusion Criteria

  • 1\. Persons with severe primary respiratory disease or related complications that may be identified with COVID\-19
  • 2\. Laboratory confirmed COVID\-19 with or without symptoms
  • 3\. Pregnant and lactating mothers and those who have a pregnancy plan.
  • 4\. Persons with serious critical illness, or severe mental illnesses
  • 5\. Individuals with uncontrolled, unstable co\-morbidities
  • 6\. Immuno\-compromised individuals or those on immune\-suppressants and steroids
  • 7\. Subjects having a past history of allergy to any medicine that is part of the Unani intervention

Outcomes

Primary Outcomes

Not specified

Similar Trials